Gut Liver.
2016 Nov;10(6):869-870. 10.5009/gnl16476.
Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders!
- Affiliations
-
- 1Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea. hwiyoung@ewha.ac.kr
- KMID: 2412089
- DOI: http://doi.org/10.5009/gnl16476
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
- Lamivudine: fading into the mists of time
- Entecavir 1 mg therapy for lamivudine-refractory chronic hepatitis B
- Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
- Experience with Entecavir Therapy for Lamivudine-Resistant Chronic Hepatitis B in Korean Children and Adolescents
